Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13503)

• Formulation Name: Methsuximide 300 mg capsule
• Company: Parke-Davis Div of Pfizer Inc

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methsuximide	(DM6L5VO)	Absence epilepsy		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant